Skip to content

Could a Preoperative Feeding Jejunostomy Decrease Sarcopenia for Patients With Oesogastric Adenocarcinoma ?

Could a Preoperative Feeding Jejunostomy Decrease Sarcopenia for Patients With Oesogastric Adenocarcinoma ?

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03574116
Enrollment
40
Registered
2018-06-29
Start date
2018-05-31
Completion date
2019-05-31
Last updated
2018-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sarcopenia

Keywords

Sarcopenia, jejunostomy, oesogastric adenocarcinoma, scanography

Brief summary

The study of sarcopenia is a subject that is the subject of numerous research and publications, particularly because of its link with a poor prognosis for many cancers. In an article published by the digestive surgery team, the role of feeding jejunostomy has been demonstrated: it allowed more patients to reach the 2nd stage of surgery and a better tolerance of chemotherapy. Investigators wanted to study retrospectively the impact of feeding jejunostomy on radiological sarcopenia. Is the positive effect of jejunostomy in gastric cancers associated with a decrease in sarcopenia?

Interventions

None listed

Sponsors

University Hospital, Strasbourg, France
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

Criteria for inclusion: * Age 18-80 years * Sex: H or F * Subject giving their consent for their participation * Gastric cancers * stage\> IB * whether or not a feeding jejunostomy * CT scan performed at the HUS, after the end of the courses of chemotherapy and / or before the surgery.

Exclusion criteria

* antecedent level L3 surgery, * psoas hematoma * No CT performed at HUS at the end of chemotherapy and / or before surgery * Impossibility of giving the subject informed information * Subject under the protection of justice * Subject under guardianship or curatorship

Design outcomes

Primary

MeasureTime frameDescription
Evaluate muscle status by CT evaluation of sarcopenia in patients24 hour after the realization of the MRIEvaluate the impact of feeding jejunostomy in patients with gastric cancer

Countries

France

Contacts

Primary ContactFrancis VEILLON, MD, PhD
Francis.veillon@chru-strasbourg.fr33 3 88 12 78 65
Backup ContactAïna VENKATASAMY, MD
aina.venkatasamy@chru-strasbourg.fr33 3 88 12 78 65

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026